Ebglyss (lebrikizumab)

pCPA File Number: 22803

Negotiation Status:

Under consideration for negotiation

Indication(s):

Atopic dermatitis

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CDA-AMC Project Number:

SR0819-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable